The stock of Celldex Therapeutics Inc. (CLDX) has seen a -16.13% decrease in the past week, with a -27.20% drop in the past month, and
The stock of Celldex Therapeutics Inc. (NASDAQ: CLDX) has decreased by -16.28 when compared to last closing price of 40.96. Despite this, the company has
Celldex Therapeutics Inc. (NASDAQ: CLDX) has seen a rise in its stock price by 1.48 in relation to its previous close of 41.24. However, the
Additionally, the 36-month beta value for CLDX is 1.57. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1
© 2024, Powered by Smart TechOne
